Anti-Human RXFP1 Therapeutic Antibody (22DA22)
Recombinant monoclonal antibody 22DA22 is a mouse monoclonal antibody that specifically binds to human LGR7 and can be potentially used in the treatment of cancers such as ovarian cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0660CL |
| Pricing | Inquiry |
| Applications | WB, ICC, FC |
| Host | Mouse |
| Target | LGR7 (Relaxin/insulin-like family peptide receptor 1) |